Screener
CytomX Therapeutics CTMX Deemed Dividend On Warrants
Deemed Dividend On Warrants at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept ctmx:DeemedDividendOnWarrants.
The source filing: CytomX Therapeutics’s 10-K, filed March 16, 2026.
- Filed
- Mar 16, 2026, 7:01 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-107146
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 |
|---|---|---|
| Income (loss) before income taxes | (17,130) | 32,093 |
| Provision for income taxes | 238 | 224 |
| Net income (loss) | (17,368) | 31,869 |
| Deemed dividend on warrants | (3,002) | — |
| Net income (loss) attributable to common stockholders | $(20,370) | $31,869 |
| Other comprehensive income (loss): | ||
| Unrealized gain (loss) on available-for-sale investments, net of tax | 84 | (68) |
| Total comprehensive income (loss) | $(17,284) | $31,801 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is CytomX Therapeutics's deemed dividend on warrants?
- CytomX Therapeutics (CTMX) reported deemed dividend on warrants of -$750.5K in Q4 2025.
- What does deemed dividend on warrants mean?
- Deemed Dividend On Warrants as reported by CytomX Therapeutics, Inc..
Ask your AI about CytomX Therapeutics's deemed dividend on warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude